[go: up one dir, main page]

CN115594639A - A kind of Tegrazan key intermediate synthetic method - Google Patents

A kind of Tegrazan key intermediate synthetic method Download PDF

Info

Publication number
CN115594639A
CN115594639A CN202211339228.4A CN202211339228A CN115594639A CN 115594639 A CN115594639 A CN 115594639A CN 202211339228 A CN202211339228 A CN 202211339228A CN 115594639 A CN115594639 A CN 115594639A
Authority
CN
China
Prior art keywords
formula
compound
acid
reaction
stirring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211339228.4A
Other languages
Chinese (zh)
Inventor
周章涛
叶伟平
费安杰
汪辉
王道功
韩小东
黄富任
严凯伦
张毅琳
吴春林
于璐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Hwagen Pharmaceutical Co ltd
Original Assignee
Shenzhen Hwagen Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Hwagen Pharmaceutical Co ltd filed Critical Shenzhen Hwagen Pharmaceutical Co ltd
Priority to CN202211339228.4A priority Critical patent/CN115594639A/en
Publication of CN115594639A publication Critical patent/CN115594639A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

A method for synthesizing 4-hydroxy-N, 2-trimethylbenzimidazole-6-formamide, wherein the method comprises the following steps:
Figure DDA0003915805510000011
the 4-hydroxy-N, N, 2-trimethylbenzimidazole-6-formamide synthesized by the method has the advantages of novel process route, total molar yield of more than 70 percent, short route, high chemical purity of products and easy production.

Description

一种特戈拉赞关键中间体合成方法A kind of Tegrazan key intermediate synthetic method

技术领域technical field

本发明涉及有机化学合成领域,具体涉及一种制备特戈拉赞关键中间体(4-羟基-N,N,2-三甲基苯并咪唑-6-甲酰胺)的方法。The invention relates to the field of organic chemical synthesis, in particular to a method for preparing a key intermediate of tergorazan (4-hydroxy-N,N,2-trimethylbenzimidazole-6-carboxamide).

背景技术Background technique

4-羟基-N,N,2-三甲基苯并咪唑-6-甲酰胺是合成质子泵抑制剂特戈拉赞(tegoprazan)的关键中间体。4-Hydroxy-N,N,2-trimethylbenzimidazole-6-carboxamide is a key intermediate in the synthesis of proton pump inhibitor tegoprazan.

目前这一中间体主要有1条合成路线。如下路线所示。该路线需要较为繁琐的基团保护,使用2-氨基-3-硝基-5-溴苯酚为起始物料,先进行O-苄基保护,之后对氨基进行乙酰化保护,在铁粉/乙酸条件下还原硝基并发生缩合关环得到苯并咪唑骨架;在过渡金属催化下将溴转化为氰基;随后水解氰基得到羧酸,与二甲胺经缩合剂反应得到酰胺;最终钯催化氢化脱O-苄基得到4-羟基-N,N,2-三甲基苯并咪唑-6-甲酰胺。Currently, there is mainly one synthetic route for this intermediate. as shown in the route below. This route requires relatively complicated group protection, using 2-amino-3-nitro-5-bromophenol as the starting material, first carrying out O-benzyl protection, and then carrying out acetylation protection on the amino group, in iron powder/acetic acid Reduction of the nitro group under certain conditions and condensation and ring closure to obtain the benzimidazole skeleton; conversion of bromine to cyano group under transition metal catalysis; subsequent hydrolysis of cyano group to obtain carboxylic acid, reaction with dimethylamine through a condensation agent to obtain amide; final palladium catalyzed Hydrogenation deO-benzyl to give 4-hydroxy-N,N,2-trimethylbenzimidazole-6-carboxamide.

CN 101341149 ACN 101341149 A

Figure BDA0003915805490000011
Figure BDA0003915805490000011

CN113527272ACN113527272A

Figure BDA0003915805490000021
Figure BDA0003915805490000021

除了起始物料比较昂贵,该路线前两步需要依次对氧、氮原子进行保护,在还原硝基过程中使用铁粉/冰乙酸体系,大大增加了后处理难度;在引入羧基过程需要经过溴代、金属催化引入氰基,试剂处理危险性增加,且所得羧酸中间体极性大,难以纯化处理。In addition to the relatively expensive starting materials, the first two steps of this route need to protect oxygen and nitrogen atoms in turn. The use of iron powder/glacial acetic acid system in the process of reducing nitro groups greatly increases the difficulty of post-treatment; the process of introducing carboxyl groups requires bromine The introduction of cyano groups by generation and metal catalysis increases the risk of reagent handling, and the resulting carboxylic acid intermediates are highly polar and difficult to purify.

综上所述,制药行业的发展需要4-羟基-N,N,2-三甲基苯并咪唑-6-甲酰胺这一类医药中间体,然而其目前的合成方法还有较大改进空间。In summary, the development of the pharmaceutical industry requires pharmaceutical intermediates such as 4-hydroxy-N,N,2-trimethylbenzimidazole-6-carboxamide, but there is still much room for improvement in its current synthesis methods .

发明内容Contents of the invention

为改善4-羟基-N,N,2-三甲基苯并咪唑-6-甲酰胺的产品合成路线长、原料无大宗供应,生产成本高等缺点,本发明开发了新的工艺路线。具体包括以下反应步骤:In order to improve the disadvantages of 4-hydroxy-N,N,2-trimethylbenzimidazole-6-carboxamide, such as long synthetic route, no bulk supply of raw materials, and high production cost, the present invention develops a new process route. Concretely comprise following reaction steps:

1)式Ⅰ的化合物与二甲胺在缩合剂的作用下发生酸胺缩合,生成化合物II;1) The compound of formula I and dimethylamine undergo acid amine condensation under the action of a condensing agent to generate compound II;

2)式Ⅱ的化合物在酸性条件下与溴素、NBS或二溴海因等溴代试剂发生二溴代反应生成化合物Ⅲ;2) The compound of formula II undergoes a dibromination reaction with a brominated reagent such as bromine, NBS or dibromohydantoin under acidic conditions to generate compound III;

3)式Ⅲ的化合物与乙脒或其盐的形态在碱及过渡金属催化下在高沸点溶剂中发生关环反应生成化合物Ⅳ;3) The form of the compound of formula III and acetamidine or its salt undergoes a ring-closing reaction in a high boiling point solvent under the catalysis of alkali and transition metal to generate compound IV;

4)式Ⅳ的化合物与卤化苄在碱存在下发生亲核取代生成苄基保护的化合物Ⅴ;4) Nucleophilic substitution between the compound of formula IV and benzyl halide in the presence of a base to generate benzyl-protected compound V;

5)式Ⅴ的化合物在过渡金属催化的条件下,在碱存在下与硼酯试剂偶联生成化合物Ⅵ,或与烷基锂试剂活化,而后与硼酯化试剂反应生成化合物Ⅵ;5) The compound of formula V is coupled with a boroester reagent in the presence of a base to generate compound VI under the condition of transition metal catalysis, or activated with an alkyllithium reagent, and then reacted with a boroesterification reagent to generate compound VI;

6)式Ⅵ的化合物与过氧化试剂,如双氧水、m-CPBA等在水存在下发生脱硼氧化反应生成化合物Ⅶ;6) The compound of formula VI reacts with a peroxidation reagent, such as hydrogen peroxide, m-CPBA, etc., in the presence of water to generate compound VII;

7)式Ⅶ的化合物在酸性条件下或过渡金属催化氢化条件下发生脱苄基反应生成化合物Ⅷ。7) The compound of formula VII undergoes a debenzylation reaction under acidic conditions or transition metal-catalyzed hydrogenation conditions to generate compound VIII.

Figure BDA0003915805490000031
Figure BDA0003915805490000031

最终产物即化合物VIII的CAS为2168520-25-8。The CAS of the final product, compound VIII, is 2168520-25-8.

本发明优选实施方案:Preferred embodiment of the present invention:

步骤1)所述的缩合试剂选自羰基二咪唑、1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐和2-(7-偶氮苯并三氮唑)-N,N,N',N'-四甲基脲六氟磷酸酯中的至少一种,优选羰基二咪唑,因其成本较低,副产物为咪唑,相比于其他缩合剂属环境友好型试剂。The condensation reagent described in step 1) is selected from carbonyldiimidazole, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and 2-(7-azobenzotriazole At least one of )-N,N,N',N'-tetramethyluronium hexafluorophosphate, preferably carbonyldiimidazole, because of its low cost, the by-product is imidazole, which is environmentally friendly compared to other condensing agents friendly reagents.

步骤2)所述的酸选自醋酸、三氟乙酸中的至少一种,所述溴代试剂选自溴素、N-溴代丁二酰亚胺、二溴海因、三溴化吡啶盐中的至少一种;优选的,所述酸为醋酸,所述溴代试剂为溴素,相比于三氟乙酸,醋酸成本低廉、腐蚀性弱、易操作,且不会对环境造成影响。相比于其他溴代试剂,溴素为其产业链上游试剂。Step 2) the acid is selected from at least one of acetic acid and trifluoroacetic acid, and the brominated reagent is selected from bromine, N-bromosuccinimide, dibromohydantoin, and pyridinium tribromide At least one of them; preferably, the acid is acetic acid, and the brominating agent is bromine. Compared with trifluoroacetic acid, acetic acid is low in cost, weak in corrosion, easy to operate, and will not affect the environment. Compared with other brominated reagents, bromine is an upstream reagent in the industrial chain.

步骤3)所述的碱选自碳酸钾、碳酸铯、磷酸钾、氢氧化钾中的至少一种,所述过渡金属催化剂选自亚铜试剂、钯催化剂中的至少一种;所述高沸点溶剂选自N-甲基吡咯烷酮、二甲基亚砜,DMAc、DMF中的至少一种,优选的,所述碱为磷酸钾、所述过渡金属催化剂为亚铜催化剂,所述高沸点溶剂为二甲基亚砜,选择这些试剂可以获得反应速度快,转化率高,且杂质含量低的有益效果;Step 3) the alkali is selected from at least one of potassium carbonate, cesium carbonate, potassium phosphate, potassium hydroxide, and the transition metal catalyst is selected from at least one of cuprous reagent and palladium catalyst; the high boiling point The solvent is selected from at least one of N-methylpyrrolidone, dimethyl sulfoxide, DMAc, and DMF. Preferably, the base is potassium phosphate, the transition metal catalyst is a cuprous catalyst, and the high boiling point solvent is Dimethyl sulfoxide, choosing these reagents can obtain the beneficial effects of fast reaction speed, high conversion rate and low impurity content;

步骤4)所述的卤化苄为溴苄或氯苄,所述的碱选自氢氧化钠、氢氧化钾、钙氢、钠氢、双三甲硅基氨基锂、双三甲硅基氨基钠和正丁基锂中的至少一种,优选反应活性较高的溴苄、钠氢为反应条件;The benzyl halide described in step 4) is benzyl bromide or benzyl chloride, and the base is selected from sodium hydroxide, potassium hydroxide, calcium hydrogen, sodium hydrogen, lithium bistrimethylsilamide, sodium bistrimethylsilamide and n-butyl At least one of base lithium, preferably the higher reactive benzyl bromide and sodium hydrogen are the reaction conditions;

步骤5)所述催化剂选自钯、铜等过度金属催化剂,所述的碱选自醋酸钾、醋酸钠中的至少一种,优选的,催化剂为三(二亚苄丙酮)二钯,碱为醋酸钾,因为反应选择性更好;Step 5) The catalyst is selected from transition metal catalysts such as palladium and copper, and the base is selected from at least one of potassium acetate and sodium acetate. Preferably, the catalyst is tris(dibenzylideneacetone) dipalladium, and the base is Potassium acetate, because the reaction selectivity is better;

步骤6)所述的氧化试剂选自过氧化氢水溶液、间氯过氧苯甲酸中的至少一种,优选过氧化氢水溶液,因其成本更低、环境更友好;Step 6) the oxidation reagent is selected from at least one of aqueous hydrogen peroxide solution and m-chloroperoxybenzoic acid, preferably aqueous hydrogen peroxide solution, because of its lower cost and more environmentally friendly;

步骤7)所述的过渡金属催化剂选自钯碳、铂碳、雷尼镍、钌、铑和铱中的至少一种,所述的酸选自盐酸、硫酸、甲酸、乙酸、三氟乙酸和三氟甲磺酸中的至少一种,优选的,过渡金属催化剂为钯碳,酸为醋酸,因为选择这些试剂易放大操作、且成本更低。Step 7) the transition metal catalyst is selected from at least one of palladium carbon, platinum carbon, Raney nickel, ruthenium, rhodium and iridium, and the acid is selected from hydrochloric acid, sulfuric acid, formic acid, acetic acid, trifluoroacetic acid and At least one of the trifluoromethanesulfonic acid, preferably, the transition metal catalyst is palladium carbon, and the acid is acetic acid, because selecting these reagents is easy to scale up and operate, and the cost is lower.

根据本发明的一种实施方式,合成4-羟基-N,N,2-三甲基苯并咪唑-6-甲酰胺的方法包括:According to one embodiment of the present invention, the method for synthesizing 4-hydroxyl-N,N,2-trimethylbenzimidazole-6-carboxamide comprises:

1.1)向反应釜中加入二氯甲烷、式I的化合物、4-二甲氨基吡啶、二甲胺盐酸盐、1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐,室温搅拌反应,反应4~6h后加入水搅拌洗涤,分液。1.1) Add methylene chloride, the compound of formula I, 4-dimethylaminopyridine, dimethylamine hydrochloride, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide to the reactor Hydrochloride, stirred and reacted at room temperature, reacted for 4 to 6 hours, then added water, stirred and washed, and separated.

1.2)分离得到二氯甲烷层,对二氯甲烷层进行减压浓缩,残留物用乙酸乙酯/正庚烷体系溶解后经硅胶过滤,滤液经减压浓缩后加入正庚烷打浆、过滤、干燥,得到式II化合物。1.2) Separate the dichloromethane layer to obtain the dichloromethane layer, concentrate the dichloromethane layer under reduced pressure, dissolve the residue with ethyl acetate/n-heptane system and filter it through silica gel, add n-heptane to the filtrate after concentrating under reduced pressure to make a slurry, filter, Drying yields the compound of formula II.

2.1)向反应釜中加入冰乙酸、式II的化合物搅拌,降温至0~10℃,滴加液溴,滴加完毕后室温反应12~16小时。2.1) Add glacial acetic acid and the compound of formula II to the reaction kettle, stir, cool down to 0-10°C, add liquid bromine dropwise, and react at room temperature for 12-16 hours after the dropwise addition is completed.

2.2)加入硫代硫酸钠水溶液淬灭,搅拌,减压浓缩除去冰乙酸,加入水搅拌2~4h,过滤、干燥,得到式Ⅲ的化合物。2.2) Add sodium thiosulfate aqueous solution to quench, stir, concentrate under reduced pressure to remove glacial acetic acid, add water and stir for 2-4 hours, filter and dry to obtain the compound of formula III.

3.1)向反应釜中加入二甲基亚砜、式Ⅲ的化合物、盐酸乙脒、氧化亚铜、8-喹啉-醇、磷酸钾搅拌,抽真空,用氮气置换3次,加热到120℃反应4小时。3.1) Add dimethyl sulfoxide, compound of formula III, acetamidine hydrochloride, cuprous oxide, 8-quinoline-alcohol, potassium phosphate into the reaction kettle, stir, vacuumize, replace with nitrogen for 3 times, and heat to 120°C React for 4 hours.

3.2)向反应釜中加入水搅拌,加入醋酸调节pH至7~8,加入二氯甲烷萃取,对二氯甲烷层浓缩,加入乙酸乙酯打浆,过滤、干燥后得到式Ⅳ的化合物。3.2) Add water to the reaction kettle and stir, add acetic acid to adjust the pH to 7-8, add dichloromethane for extraction, concentrate the dichloromethane layer, add ethyl acetate for beating, filter and dry to obtain the compound of formula IV.

4.1)向反应釜中加入N-甲基吡咯烷酮、氢化钠悬浮于液面下搅拌,抽真空,用氮气置换3次,将式Ⅳ的化合物溶于N-甲基吡咯烷酮中滴加到反应釜中,之后向反应釜中滴加溴化苄,滴加完毕后在20~30℃反应10小时。4.1) Add N-methylpyrrolidone and sodium hydride to the reaction kettle, suspend it under the liquid surface and stir, vacuumize, replace with nitrogen for 3 times, dissolve the compound of formula IV in N-methylpyrrolidone and add dropwise to the reaction kettle , and then drop benzyl bromide into the reactor, and react at 20-30°C for 10 hours after the dropwise addition.

4.2)向反应釜中缓慢滴加水淬灭反应,搅拌,离心过滤、干燥后得到式Ⅴ的化合物。4.2) Slowly drop water into the reaction kettle to quench the reaction, stir, centrifugally filter and dry to obtain the compound of formula V.

5.1)向反应釜中加入甲苯、式Ⅴ的化合物、三(二亚苄丙酮)二钯、2-二环己基膦-2',4',6'-三异丙基联苯、联硼酸频那醇酯、醋酸钾,抽真空,用氮气置换3次,升温至100℃反应12小时。5.1) Add toluene, compound of formula V, tris(dibenzylideneacetone)dipalladium, 2-dicyclohexylphosphine-2',4',6'-triisopropylbiphenyl, diboronic acid frequency The alcohol ester and potassium acetate were evacuated, replaced with nitrogen for 3 times, and the temperature was raised to 100° C. for 12 hours.

5.2)向反应釜中加入水搅拌,分液,对甲苯层减压浓缩,加入乙酸乙酯/正庚烷结晶、过滤、干燥,制得式Ⅵ的化合物。5.2) Add water to the reaction kettle and stir, separate the layers, concentrate the toluene layer under reduced pressure, add ethyl acetate/n-heptane to crystallize, filter and dry to obtain the compound of formula VI.

6.1)向反应釜中加入四氢呋喃、式Ⅵ的化合物,抽真空,用氮气置换3次,降温至10℃搅拌,滴加过氧化氢,之后滴加氢氧化钠水溶液,滴加完毕继续反应4~6小时。6.1) Add tetrahydrofuran and the compound of formula VI to the reaction kettle, vacuumize, replace with nitrogen for 3 times, cool down to 10°C and stir, add hydrogen peroxide dropwise, and then add aqueous sodium hydroxide solution dropwise, and continue the reaction for 4~ 6 hours.

6.2)向反应液中滴加盐酸、搅拌,调节pH至6~7过滤,干燥,制得式Ⅶ的化合物。6.2) Add hydrochloric acid dropwise to the reaction liquid, stir, adjust the pH to 6-7, filter, and dry to obtain the compound of formula VII.

7.1)向反应釜中加入甲醇、式Ⅶ的化合物、10%钯碳、三氟乙酸,抽真空,用氮气置换3次,然后用氢气置换3次,氢气加压到0.2MPa,反应6小时。7.1) Add methanol, compound of formula VII, 10% palladium carbon, and trifluoroacetic acid into the reaction kettle, vacuumize, replace with nitrogen for 3 times, then replace with hydrogen for 3 times, pressurize the hydrogen to 0.2MPa, and react for 6 hours.

7.2)过滤,滤液加入碳酸钠水溶液调节pH至7,过滤,滤饼粗品加入乙酸乙酯打浆、过滤、干燥,制得式Ⅷ的化合物。7.2) Filtration, adding sodium carbonate aqueous solution to the filtrate to adjust the pH to 7, filtering, adding ethyl acetate to the crude filter cake, beating, filtering, and drying to obtain the compound of formula VIII.

本发明合成4-羟基-N,N,2-三甲基苯并咪唑-6-甲酰胺的方法具有工艺路线新颖、原料价廉易得、产品化学纯度高、易于放大生产等优点。The method for synthesizing 4-hydroxy-N,N,2-trimethylbenzimidazole-6-carboxamide of the present invention has the advantages of novel process route, cheap and easy-to-obtain raw materials, high chemical purity of the product, easy scale-up production and the like.

采用本发明的合成方法合成4-羟基-N,N,2-三甲基苯并咪唑-6-甲酰胺,工艺路线新颖,总摩尔收率大于70%,具有路线简短、产品化学纯度高、易于生产的特点。Synthesizing 4-hydroxy-N, N, 2-trimethylbenzimidazole-6-carboxamide by adopting the synthesis method of the present invention, the process route is novel, the total molar yield is greater than 70%, and the route is short, the product has high chemical purity, Ease of production features.

附图说明Description of drawings

为了更清楚地说明本发明实施例的技术方案,下面将对实施例的附图作简单地介绍,显然,下面描述中的附图仅仅涉及本发明的一些实施例,而非对本发明的限制。In order to illustrate the technical solutions of the embodiments of the present invention more clearly, the drawings of the embodiments will be briefly introduced below. Apparently, the drawings in the following description only relate to some embodiments of the present invention, rather than limiting the present invention.

图1为实施例中制备的化合物Ⅷ的核磁氢谱图。Figure 1 is the H NMR spectrum of compound VIII prepared in the examples.

具体实施方式detailed description

为使本发明的目的、技术方案和优点更加清楚明白,以下结合具体实施例,并参照附图,对本发明进一步详细说明。但本领域技术人员知晓,本发明并不局限于附图和以下实施例。In order to make the object, technical solution and advantages of the present invention clearer, the present invention will be described in further detail below in conjunction with specific embodiments and with reference to the accompanying drawings. However, those skilled in the art know that the present invention is not limited to the drawings and the following embodiments.

S1:脱水缩合S1: dehydration condensation

向反应瓶中加入二氯甲烷500mL、对氨基苯甲酸50g、盐酸二甲胺39g、羰基二咪唑91g、4-二甲氨基吡啶94g。氮气保护下保温25℃搅拌反应。反应完毕后加入水搅拌,静置分液,二氯甲烷层经硅胶过滤,滤液浓缩,加入正庚烷打浆,干燥,得到化合物Ⅱ54g,收率达90%。1H NMR(400MHz,DMSO-d6)δ7.17–7.10(m,1H),6.60–6.48(m,1H),5.47(s,1H),2.94(s,3H).500 mL of dichloromethane, 50 g of p-aminobenzoic acid, 39 g of dimethylamine hydrochloride, 91 g of carbonyldiimidazole, and 94 g of 4-dimethylaminopyridine were added to the reaction flask. Under the protection of nitrogen, keep warm at 25°C and stir the reaction. After the reaction was completed, water was added to stir, and the liquid was separated after standing. The dichloromethane layer was filtered through silica gel, the filtrate was concentrated, and n-heptane was added to make a slurry and dried to obtain 54 g of compound II with a yield of 90%. 1 H NMR (400MHz, DMSO-d6) δ7.17–7.10(m,1H),6.60–6.48(m,1H),5.47(s,1H),2.94(s,3H).

S2:溴代S2: bromo

向反应瓶中加入化合物Ⅱ50g,醋酸150mL,降温至10℃,滴加溴素195g,滴加完毕后加热至25℃反应6小时。加入硫代硫酸钠水溶液搅拌淬灭,滴加碳酸钠水溶液调节pH=7,乙酸乙酯萃取,过硅胶,滤液浓缩得到粗品,加入少量正庚烷打浆、过滤,干燥后得到化合物Ⅲ81g,收率达82%。1H NMR(400MHz,Chloroform-d)δ7.53(s,1H),4.78(s,1H),3.07(s,4H).Add 50 g of compound II and 150 mL of acetic acid into the reaction flask, cool down to 10°C, add 195 g of bromine dropwise, and heat to 25°C for 6 hours after the dropwise addition. Add sodium thiosulfate aqueous solution and stir to quench, add dropwise sodium carbonate aqueous solution to adjust pH = 7, extract with ethyl acetate, pass through silica gel, and concentrate the filtrate to obtain a crude product, add a small amount of n-heptane for slurry, filter, and dry to obtain 81 g of compound III. up to 82%. 1 H NMR (400MHz, Chloroform-d) δ7.53(s,1H),4.78(s,1H),3.07(s,4H).

S3:缩合关环S3: Condensation closed loop

向反应瓶中加入化合物Ⅲ20g,二甲基亚砜100mL,盐酸乙脒12g,氧化亚铜0.9g,8-喹啉-醇1.8g,磷酸钾71.5g,抽真空,氮气置换3次,氮气保护下加热到120℃反应4小时。加入醋酸调节pH至6~7,用二氯甲烷萃取,浓缩二氯甲烷层得到粗品。用少量乙酸乙酯打浆、过滤、干燥后得到化合物Ⅳ15.8g,收率90%。1H NMR(400MHz,DMSO-d6)δ12.72(s,0H),7.47(s,0H),7.36(d,J=1.4Hz,0H),2.97(s,2H),2.53(s,1H).Add 20g of compound III, 100mL of dimethyl sulfoxide, 12g of acetamidine hydrochloride, 0.9g of cuprous oxide, 1.8g of 8-quinoline-alcohol, 71.5g of potassium phosphate into the reaction flask, vacuumize, replace with nitrogen three times, and protect with nitrogen Heated to 120°C for 4 hours. Add acetic acid to adjust the pH to 6-7, extract with dichloromethane, and concentrate the dichloromethane layer to obtain a crude product. Slurry with a small amount of ethyl acetate, filter and dry to obtain 15.8 g of compound IV with a yield of 90%. 1 H NMR (400MHz, DMSO-d6) δ12.72(s, 0H), 7.47(s, 0H), 7.36(d, J=1.4Hz, 0H), 2.97(s, 2H), 2.53(s, 1H ).

S4:N-苄基保护S4: N-benzyl protection

向反应瓶1中加入N-甲基吡咯烷酮130mL、氢化钠13g悬浮搅拌,抽真空,用氮气置换3次,降温至0℃,在反应瓶2中将化合物Ⅳ100g溶于N-甲基吡咯烷酮500mL中,将所得溶液滴加到反应瓶1中,之后向反应瓶1中滴加溴化苄36.4g,滴加完毕加热至25℃反应10小时。向反应釜中滴加水淬灭,过滤,滤饼水洗、干燥后得到化合物Ⅴ48g,收率92%。1H NMR(400MHz,DMSO-d6)δ7.63(d,J=1.3Hz,1H),7.42(d,J=1.3Hz,1H),7.37–7.31(m,2H),7.31–7.25(m,1H),7.19–7.09(m,2H),5.54(s,2H),2.93(d,J=26.4Hz,6H),2.57(s,3H).Add 130mL of N-methylpyrrolidone and 13g of sodium hydride to the reaction bottle 1, suspend and stir, vacuumize, replace with nitrogen for 3 times, cool down to 0°C, and dissolve 100g of compound IV in 500mL of N-methylpyrrolidone in the reaction bottle 2 , the resulting solution was added dropwise to reaction flask 1, and then 36.4 g of benzyl bromide was added dropwise to reaction flask 1, and after the addition was completed, it was heated to 25° C. for 10 hours of reaction. Water was added dropwise into the reactor to quench, filtered, and the filter cake was washed with water and dried to obtain 48 g of Compound V with a yield of 92%. 1 H NMR (400MHz, DMSO-d6) δ7.63(d, J=1.3Hz, 1H), 7.42(d, J=1.3Hz, 1H), 7.37–7.31(m, 2H), 7.31–7.25(m ,1H),7.19–7.09(m,2H),5.54(s,2H),2.93(d,J=26.4Hz,6H),2.57(s,3H).

S5:硼酯化反应S5: boroesterification reaction

向反应瓶中加入化合物Ⅴ30g、联硼酸频那醇酯52g、甲苯150mL、三(二亚苄丙酮)二钯0.74g、2-二环己基膦-2',4',6'-三异丙基联苯0.77g、醋酸钾12g,抽真空,用氮气置换3次,加热至100℃反应12小时。向反应釜中加入水搅拌,静置分液,浓缩甲苯层得到粗品。粗品用乙酸乙酯/正庚烷结晶、过滤、干燥后得式Ⅵ化合物28.9g,收率85%。Add 30g of compound V, 52g of pinacol diboronate, 150mL of toluene, 0.74g of tris(dibenzylideneacetone)dipalladium, 2-dicyclohexylphosphine-2',4',6'-triisopropyl Base biphenyl 0.77g, potassium acetate 12g, vacuumize, replace with nitrogen 3 times, heat to 100 ℃ and react for 12 hours. Add water to the reaction kettle and stir, let stand to separate the liquid, and concentrate the toluene layer to obtain the crude product. The crude product was crystallized from ethyl acetate/n-heptane, filtered, and dried to obtain 28.9 g of the compound of formula VI, with a yield of 85%.

S6:氧化反应S6: oxidation reaction

向反应瓶中加入化合物Ⅵ0.2g,四氢呋喃20mL,抽真空,用氮气置换3次,冷却至10℃搅拌,滴加30%过氧化氢0.2g,之后滴加1M氢氧化钠水溶液0.08mL,滴加完毕继续反应6小时。向反应釜中滴加稀盐酸淬灭,调节pH至6~7,过滤,水洗,干燥后得式Ⅶ的化合物0.15g,收率82%。1H NMR(400MHz,Methanol-d4)δ7.38–7.25(m,1H),7.17–7.11(m,1H),6.96–6.93(m,0H),6.68(d,J=1.3Hz,0H),5.46(s,1H),3.08(s,1H),2.97(s,1H),2.58(s,1H).Add 0.2g of compound VI and 20mL of tetrahydrofuran to the reaction flask, vacuumize, replace with nitrogen three times, cool to 10°C and stir, add 0.2g of 30% hydrogen peroxide dropwise, and then add 0.08mL of 1M aqueous sodium hydroxide solution dropwise, After the addition was complete, the reaction was continued for 6 hours. Dilute hydrochloric acid was added dropwise into the reaction kettle to quench, adjust the pH to 6-7, filter, wash with water, and dry to obtain 0.15 g of the compound of formula VII with a yield of 82%. 1 H NMR (400MHz, Methanol-d4) δ7.38–7.25(m,1H),7.17–7.11(m,1H),6.96–6.93(m,0H),6.68(d,J=1.3Hz,0H) ,5.46(s,1H),3.08(s,1H),2.97(s,1H),2.58(s,1H).

S7:氢化脱苄S7: Hydrodebenzylation

向反应瓶中加入化合物Ⅶ50g,甲醇500mL,三氟乙酸5g,10%钯碳2.5g,抽真空,用氮气置换3次,然后用氢气置换3次。氢气加压到0.2MPa,反应6小时。过滤,向滤液中滴加碳酸钠水溶液调节pH至7,过滤得到粗品。加入少量乙酸乙酯打浆、过滤、干燥后得到化合物Ⅷ29.5g,收率85%。化合物Ⅷ的核磁氢谱图参见附图1。1HNMR(400MHz,Methanol-d4)δ7.23(s,1H),6.93(s,1H),3.14(s,3H),3.03(s,3H),2.86(s,3H).)Add 50 g of compound VII, 500 mL of methanol, 5 g of trifluoroacetic acid, and 2.5 g of 10% palladium on carbon into the reaction flask, vacuumize, replace with nitrogen for 3 times, and then replace with hydrogen for 3 times. The hydrogen gas was pressurized to 0.2MPa, and the reaction was carried out for 6 hours. After filtration, aqueous sodium carbonate solution was added dropwise to the filtrate to adjust the pH to 7, and the crude product was obtained by filtration. A small amount of ethyl acetate was added to make a slurry, filtered and dried to obtain 29.5 g of compound VIII with a yield of 85%. Please refer to accompanying drawing 1 for the H NMR spectrum of compound VIII. 1 H NMR (400MHz,Methanol-d4)δ7.23(s,1H),6.93(s,1H),3.14(s,3H),3.03(s,3H),2.86(s,3H).)

综上,该路线采用价廉易得的大宗化学品4-氨基苯甲酸为起始原料,采用价廉易得的基础物料溴素进行双溴代,继而采用成本较低的亚铜催化剂进行关环,而后以另一个溴位点为基础构建羟基,相对于原路线本路线物料成本更低,步骤简洁,过程不涉及影响工业化生产的特殊反应。In summary, this route uses the cheap and easy-to-obtain bulk chemical 4-aminobenzoic acid as the starting material, uses the cheap and easy-to-obtain basic material bromine for double bromination, and then uses the lower-cost cuprous catalyst for close ring, and then build a hydroxyl group on the basis of another bromine site. Compared with the original route, the material cost of this route is lower, the steps are simple, and the process does not involve special reactions that affect industrial production.

Claims (10)

1. A method for synthesizing 4-hydroxy-N, 2-trimethylbenzimidazole-6-formamide, which is characterized in that the route of the method is as follows:
Figure FDA0003915805480000011
2. method according to claim 1, characterized in that it comprises the following steps:
1) Carrying out acid-amine condensation on the compound shown in the formula I and dimethylamine under the action of a condensing agent to generate a compound shown in a formula II;
2) Carrying out dibromo reaction on the compound of the formula II and a brominating agent in the presence of acid to generate a compound of a formula III;
3) Carrying out a ring closure reaction on a compound shown in a formula III and acetamidine or salt thereof in a high-boiling-point solvent under the catalysis of alkali and a transition metal catalyst to generate a compound shown in a formula IV;
4) Nucleophilic substitution of the compound of formula IV with benzyl halide in the presence of a base to produce a benzyl-protected compound of formula V;
5) Under the condition of catalyst catalysis, the compound of the formula V is coupled with a boron ester reagent in the presence of alkali to generate a compound of a formula VI, or is activated with an alkyl lithium reagent and then reacts with a boron esterification reagent to generate a compound of the formula VI;
6) Carrying out boron-removing oxidation reaction on the compound of the formula VI and a peroxidation reagent in the presence of water to generate a compound of a formula VII;
7) The compound of the formula VII is subjected to debenzylation reaction under acidic condition or hydrogenation condition in the presence of transition metal catalyst to generate the compound of the formula VIII.
3. The method according to claim 2, wherein the condensing agent of step 1) is at least one selected from the group consisting of carbonyldiimidazole, 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride and 2- (7-azobenzotriazol) -N, N, N ', N' -tetramethyluronium hexafluorophosphate, preferably carbonyldiimidazole.
4. The method according to claim 2, wherein the acid in step 2) is selected from at least one of acetic acid and trifluoroacetic acid, and the brominating agent is selected from at least one of bromine, N-bromosuccinimide, dibromohydantoin and pyridinium tribromide;
preferably, the acid is acetic acid and the brominating agent is bromine.
5. The method of claim 2, wherein the base of step 3) is selected from at least one of potassium carbonate, cesium carbonate, potassium phosphate, and potassium hydroxide, and the transition metal catalyst is selected from at least one of cuprous reagent and palladium catalyst; the high boiling point solvent is at least one selected from N-methyl pyrrolidone, dimethyl sulfoxide, DMAc and DMF;
preferably, the alkali is potassium phosphate, the transition metal catalyst is a cuprous catalyst, and the high-boiling point solvent is dimethyl sulfoxide.
6. The method according to claim 2, wherein the benzyl halide in the step 4) is benzyl bromide or benzyl chloride, and the base is at least one selected from the group consisting of sodium hydroxide, potassium hydroxide, calcium hydrogen, sodium hydrogen, lithium bis-trisilyl amide, sodium bis-trisilyl amide and n-butyl lithium;
preferably, the benzyl halide is benzyl bromide, and the base is sodium hydrogen.
7. The method according to claim 2, wherein the catalyst of step 5) is a transition metal catalyst, preferably, the transition metal catalyst is at least one selected from palladium compounds and copper compounds; the alkali is at least one selected from potassium acetate and sodium acetate, preferably, the catalyst is tris (dibenzylideneacetone) dipalladium, and the alkali is potassium acetate.
8. The process according to claim 2, wherein the oxidizing agent of step 6) is selected from at least one of aqueous hydrogen peroxide and m-chloroperoxybenzoic acid, preferably aqueous hydrogen peroxide.
9. The method according to claim 2, wherein the transition metal catalyst of step 7) is at least one selected from palladium on carbon, platinum on carbon, raney nickel, ruthenium, rhodium and iridium, and the acid is at least one selected from hydrochloric acid, sulfuric acid, formic acid, acetic acid, trifluoroacetic acid and trifluoromethanesulfonic acid; preferably, the transition metal catalyst is palladium on carbon and the acid is acetic acid.
10. The method according to any one of claims 1-9, characterized in that the method comprises:
1.1 Adding dichloromethane, the compound of the formula I, 4-dimethylaminopyridine, dimethylamine hydrochloride and 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride into a reaction kettle, stirring at room temperature for reaction, reacting for 4-6 h, adding water, stirring, washing and separating;
1.2 Separating to obtain a dichloromethane layer, concentrating the dichloromethane layer under reduced pressure, dissolving the residue with ethyl acetate/n-heptane system, filtering with silica gel, concentrating the filtrate under reduced pressure, adding n-heptane, pulping, filtering, and drying to obtain compound of formula II;
2.1 Adding glacial acetic acid and the compound of the formula II into a reaction kettle, stirring, cooling to 0-10 ℃, dropwise adding liquid bromine, and reacting at room temperature for 12-16 hours after dropwise adding;
2.2 Adding sodium thiosulfate aqueous solution for quenching, stirring, decompressing and concentrating to remove glacial acetic acid, adding water for stirring for 2-4 h, filtering and drying to obtain a compound shown in a formula III;
3.1 Adding dimethyl sulfoxide, a compound of a formula III, acetamidine hydrochloride, cuprous oxide, 8-quinol-ol and potassium phosphate into a reaction kettle, stirring, vacuumizing, replacing for 3 times with nitrogen, and heating to 120 ℃ for reaction for 4 hours;
3.2 Adding water into a reaction kettle, stirring, adding acetic acid to adjust the pH value to 7-8, adding dichloromethane for extraction, concentrating a dichloromethane layer, adding ethyl acetate for pulping, filtering and drying to obtain a compound shown in the formula IV;
4.1 Adding N-methyl pyrrolidone and sodium hydride suspended below the liquid level into a reaction kettle, stirring, vacuumizing, replacing with nitrogen for 3 times, dissolving the compound shown in the formula IV into the N-methyl pyrrolidone, dropwise adding benzyl bromide into the reaction kettle, and reacting at 20-30 ℃ for 10 hours after dropwise adding;
4.2 Slowly dropwise adding water into the reaction kettle to quench and react, stirring, centrifugally filtering and drying to obtain a compound shown in the formula V;
5.1 Adding toluene, the compound of formula V, tris (dibenzylideneacetone) dipalladium, 2-dicyclohexylphosphine-2 ',4',6' -triisopropylbiphenyl, pinacol diboron diboride and potassium acetate into a reaction kettle, vacuumizing, replacing 3 times with nitrogen, and heating to 100 ℃ for reaction for 12 hours;
5.2 Adding water into a reaction kettle, stirring, separating, concentrating a toluene layer under reduced pressure, adding ethyl acetate/n-heptane for crystallization, filtering and drying to obtain a compound shown in a formula VI;
6.1 Adding tetrahydrofuran and a compound shown in a formula VI into a reaction kettle, vacuumizing, replacing for 3 times by nitrogen, cooling to 10 ℃, stirring, dropwise adding hydrogen peroxide, dropwise adding a sodium hydroxide aqueous solution, and continuously reacting for 4-6 hours after dropwise adding;
6.2 Dropwise adding hydrochloric acid into the reaction solution, stirring, adjusting the pH value to 6-7, filtering, and drying to obtain a compound shown in the formula VII;
7.1 Adding methanol, the compound of the formula VII, 10% palladium carbon and trifluoroacetic acid into a reaction kettle, vacuumizing, replacing for 3 times with nitrogen, then replacing for 3 times with hydrogen, pressurizing to 0.2MPa with hydrogen, and reacting for 6 hours;
7.2 Filtering, adding sodium carbonate aqueous solution into the filtrate to adjust the pH value to 7, filtering, adding ethyl acetate into the crude filter cake, pulping, filtering and drying to obtain the compound shown in the formula VIII.
CN202211339228.4A 2022-10-28 2022-10-28 A kind of Tegrazan key intermediate synthetic method Pending CN115594639A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211339228.4A CN115594639A (en) 2022-10-28 2022-10-28 A kind of Tegrazan key intermediate synthetic method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211339228.4A CN115594639A (en) 2022-10-28 2022-10-28 A kind of Tegrazan key intermediate synthetic method

Publications (1)

Publication Number Publication Date
CN115594639A true CN115594639A (en) 2023-01-13

Family

ID=84851628

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211339228.4A Pending CN115594639A (en) 2022-10-28 2022-10-28 A kind of Tegrazan key intermediate synthetic method

Country Status (1)

Country Link
CN (1) CN115594639A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116396226A (en) * 2022-12-30 2023-07-07 浙江美诺华药物化学有限公司 Preparation method of agoraphobia and intermediate compound thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113527272A (en) * 2021-08-06 2021-10-22 西安淳甄新材料有限公司 Synthesis method of Tegolazan
CN114249694A (en) * 2020-09-22 2022-03-29 浙江四维医药科技有限公司 Preparation method of texas intermediate
CN114805317A (en) * 2022-05-20 2022-07-29 江苏威奇达药业有限公司 Preparation method of Tegolrazan

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114249694A (en) * 2020-09-22 2022-03-29 浙江四维医药科技有限公司 Preparation method of texas intermediate
CN113527272A (en) * 2021-08-06 2021-10-22 西安淳甄新材料有限公司 Synthesis method of Tegolazan
CN114805317A (en) * 2022-05-20 2022-07-29 江苏威奇达药业有限公司 Preparation method of Tegolrazan

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
RICHARD P. LOACH等: "C7-Derivatization of C3-Alkylindoles Including Tryptophans and Tryptamines", 《THE JOURNAL OF ORGANIC CHEMISTRY》, vol. 79, no. 22, 24 October 2014 (2014-10-24), pages 11254 - 11263, XP093101639, DOI: 10.1021/jo502062z *
YUN-LONG HOU,等: "Dramatic improvement of stability by in situ linker cyclization of a metal–organic framework", 《CHEM. COMMUN.》, vol. 54, 31 July 2018 (2018-07-31), pages 9470 - 9473 *
柯方,等: "铜催化微波辅助合成苯并咪唑衍生物的研究", 《有机化学》, vol. 34, 31 December 2014 (2014-12-31), pages 1900 - 1904 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116396226A (en) * 2022-12-30 2023-07-07 浙江美诺华药物化学有限公司 Preparation method of agoraphobia and intermediate compound thereof

Similar Documents

Publication Publication Date Title
CN110950765A (en) A kind of preparation method of terbutaline sulfate
CN114920699B (en) Method for preparing 6-chloro-2-methyl-2H-indazol-5-amine
CN115594639A (en) A kind of Tegrazan key intermediate synthetic method
CN112552224A (en) Synthesis method of 4-hydroxyindole
CN113248432A (en) Novel method for preparing intermediate of roxasistat in high yield
CN115536593A (en) Scalable production method of 4-hydroxy-N, N, 2-trimethylbenzimidazole-6-formamide
WO2024087157A1 (en) Method for synthesizing key intermediate of tegoprazan
CN115124530B (en) A kind of preparation method of evodiamine
CN115611860B (en) Method for synthesizing nilaparib
WO2023039940A1 (en) Method for preparing n,n,n-tripivaloyl-1,3,5-triaminobenzene
CN114437085B (en) Preparation method of rebamipa intermediate
CN111100042B (en) Preparation method of 2-methoxy-5-sulfonamide benzoic acid
US12258318B2 (en) Synthesis method for 1-methyl-1H-indazole-6-carboxylic acid
WO2023151157A1 (en) Chemical intermediate and preparation method
WO2024087156A1 (en) Scalable production method for 4-hydroxy-n,n,2-trimethylbenzimidazole-6-carboxamide
CN114436952A (en) Synthesis method of 2-methoxy-3-amino-5-pyridine boronic acid pinacol ester and intermediate thereof
CN114349683B (en) Amino protection and deprotection method for carbazole and carbazole-like derivatives
CN118005537B (en) A method for preparing 1,4-cyclohexane diisocyanate
CN118724731B (en) Two-step preparation of 4-fluoro-2-methoxy-5-nitroaniline
CN115677636B (en) Preparation method of 2, 3',4' -biphenyl tetracarboxylic dianhydride
CN101844964B (en) Method for preparing octachloronaphthalene
CN117024342B (en) A method for synthesizing phenanthridine OLED material
CN115745782B (en) Preparation method and production method of phthalic acid derivative
CN115536610B (en) Preparation method of vothixetine
CN110452097B (en) Preparation method of 1-hydroxypyrene

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20230113